Collaborations, Data Partnership, Oncology

Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics

Posted on

Agreement will leverage GuardantINFORM real-world evidence platform to advance development efforts for core cancer indications August 31, 2022 08:05 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced an expanded collaboration with Merck KGaA, Darmstadt, Germany, a leading science and…

Fundraising/IPO, Government/Regulatory, Industry News

Department of Energy Announces $5 Million for Research to Develop New Models for Bio-Preparedness

Posted on

Research will advance data movement and analysis, as well as develop tools for automating workflows to aid in decision support. 31-Aug-2022 1:25 PM EDT, by Department of Energy, Office of Science favorite_border Newswise — WASHINGTON, D.C. – Today, the U.S. Department of Energy (DOE) announced $5 million in funding for research to advance the development of…

Collaborations, Competitor News, Data Partnership, Oncology, Product Updates

Syapse and Genesis Research Combine Forces to Offer Real-World Evidence Services and Data to Oncology Innovators

Posted on

SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced that they have entered into a strategic partnership with Genesis Research, combining the expertise and resources of both companies to better serve…

Collaborations, Competitor News, RWE Study

Real-World Administrative Claims Analysis Demonstrates That Almost Half of Migraine Patients Discontinue Barbiturate Use After Initiation of Nurtec ODT

Posted on

Results from this study demonstrate a robust and clinically meaningful reduction in barbiturate use after the initiation of Nurtec ODT, providing an alternative migraine therapy for those who may be reliant on butalbital or desire an alternative therapy that is not associated with addiction potential. Despite being associated with addiction…

Collaborations, Data Partnership, Industry News, RWE Study

Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions

Posted on

Abstract Studies that generate real-world evidence on the effects of medical products through analysis of digital data collected in clinical practice provide key insights for regulators, payers, and other healthcare decision-makers. Ensuring reproducibility of such findings is fundamental to effective evidence-based decision-making. We reproduce results for 150 studies published in…

Collaborations, Competitor News, Partner and Collaborator News, Product Updates

MCI Onehealth and Palantir Technologies Partner to Solve Critical Healthcare Issues and Unlock Clinical Insights

Posted on

August 30, 2022 07:30 ET | Source: MCI Onehealth Technologies, Inc. Tech and data-enabled high-performance healthcare network helps address urgent health system issues: remedying system backlogs for patient services, providing greater access to care and diagnostics, providing high-quality continuity of care, speeding time to specialist referrals, identifying optimal care pathways, while accelerating…

Collaborations, Competitor News, Data Partnership, Pharma, RWE Study

AMGEN TO PRESENT NEW, POSITIVE CLINICAL AND REAL-WORLD DATA ACROSS INFLAMMATION PORTFOLIO AT EADV 2022

Posted on

New Positive Data From Phase 3 SPROUT Trial, Studying Otezla (apremilast) in Children Ages 6-17 With Moderate to Severe Plaque Psoriasis Positive Results From the Phase 3 DISCREET Study, Investigating Clinical Efficacy and Safety of Otezla in Patients With Moderate to Severe Genital Psoriasis New Rocatinlimab Phase 2 Analyses Highlight…

Competitor News, Fundraising/IPO

CuriMeta Launches in Collaboration with BJC HealthCare and Washington University in St. Louis to Empower Researchers With Advanced Real-World Health Data

Posted on

CuriMeta secures Series Seed funding to close research gaps and accelerate development of life saving interventions ST. LOUIS, Aug. 30, 2022 /PRNewswire/ — CuriMeta, a life science-focused, real-world health data company, announced a collaboration with BJC HealthCare (BJC) and Washington University School of Medicine in St. Louis (WashU Medicine), who also led the $6 Million Series Seed Funding round. The…

Academic, Collaborations, Competitor News

WashU Medicine, BJC HealthCare partner with new company to accelerate lifesaving research

Posted on

CuriMeta aims to enable data-driven innovation for the benefit of patients August 30, 2022GETTY IMAGES Washington University School of Medicine in St. Louis and BJC HealthCare are partnering with CuriMeta, a new company based in St. Louis, that will accelerate lifesaving research in the fight against chronic and acute diseases….